Brief: 2Seventy Bio Presents Late-Breaking Results For SC-Daric33
19/05/2023 11:01
May 19 (Reuters) - 2Seventy Bio Inc TSVT.O :
* 2SEVENTY BIO PRESENTS LATE-BREAKING RESULTS FOR
SC-DARIC33, AN
INVESTIGATIONAL CD33-TARGETING CAR T IN PEDIATRIC AND YOUNG
ADULTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA
Source text for Eikon: ID:nBw6bzwT3a
Further company coverage: TSVT.O
Recent news on 2Seventy Bio
See all news2Seventy Bio Inc expected to post a loss of 17 cents a share - Earnings Preview
2Seventy Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: 2Seventy Bio Q4 Basic EPS USD -0.37
2Seventy Bio Inc expected to post a loss of 26 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney